TANGO THERAPEUTICS INC. - COMMON STOCK

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

01 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

02 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG462; Provides Additional Business Updates

25 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights

10 ноя 2022 07:00:03 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

07 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of Preclinical Data on PRMT5 Inhibitors TNG908 and TNG462 in Three Abstracts Accepted at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

19 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of Preclinical Data on TNG260 and Discovery Platform Advances at SITC 37th Annual Meeting

05 окт 2022 08:10:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

06 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

10 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

02 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

27 июн 2022 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

08 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

11 май 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022

09 май 2022 07:00:02 Источник Nasdaq GlobeNewswire

Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

28 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor Program and Discovery Platform in Three Abstracts Accepted at AACR 2022 Annual Meeting

08 мар 2022 16:57:30 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 2022 ESMO Targeted Anticancer Therapies Congress

03 мар 2022 09:41:35 Источник Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

02 фев 2022 07:00:00 Источник Nasdaq GlobeNewswire

Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

24 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire